Elizabeth A Garofalo is Chairman at Exicure, Inc.

She is also on the board of ACADIA Pharmaceuticals, Inc., Xenon Pharmaceuticals, Inc., Alector, Inc. and Institute For Advanced Clinical Trials For Children and Principal at EAG Pharma Consulting LLC.

In the past Elizabeth A Garofalo occupied the position of Head-Neuroscience & Worldwide Regulatory Affairs at Pfizer Inc., Global Head-Clinical Development & Senior VP at Novartis, Inc. and VP & Head-Neuroscience Therapy Area at Astellas Pharma Global Development, Inc.

She received a doctorate from The Indiana University School of Medicine and an undergraduate degree from Purdue University.